Cargando…

Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?

Detalles Bibliográficos
Autor principal: Wei, Shu Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083256/
https://www.ncbi.nlm.nih.gov/pubmed/27799878
http://dx.doi.org/10.5217/ir.2016.14.4.293
_version_ 1782463179618516992
author Wei, Shu Chen
author_facet Wei, Shu Chen
author_sort Wei, Shu Chen
collection PubMed
description
format Online
Article
Text
id pubmed-5083256
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean Association for the Study of Intestinal Diseases
record_format MEDLINE/PubMed
spelling pubmed-50832562016-10-31 Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease? Wei, Shu Chen Intest Res Editorial Korean Association for the Study of Intestinal Diseases 2016-10 2016-10-17 /pmc/articles/PMC5083256/ /pubmed/27799878 http://dx.doi.org/10.5217/ir.2016.14.4.293 Text en © Copyright 2016. Korean Association for the Study of Intestinal Diseases. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Wei, Shu Chen
Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
title Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
title_full Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
title_fullStr Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
title_full_unstemmed Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
title_short Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
title_sort could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083256/
https://www.ncbi.nlm.nih.gov/pubmed/27799878
http://dx.doi.org/10.5217/ir.2016.14.4.293
work_keys_str_mv AT weishuchen couldfecalcalprotectinentermainstreamusefordiagnosingandmonitoringinflammatoryboweldisease